7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Acupuncture for the prevention of chemotherapy‐induced nausea and vomiting in cancer patients: A systematic review and meta‐analysis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          To assess the effectiveness and safety of acupuncture for the prevention of chemotherapy‐induced nausea and vomiting (CINV), with a specific intention on exploring sources of between‐study variation in treatment effects.

          Methods

          MEDLINE, EMBASE, Cochrane CENTRAL, CINAHL, Chinese Biomedical Literature Database, VIP Chinese Science and Technology Periodicals Database, China National Knowledge Infrastructure, and Wanfang were searched to identify randomized controlled trials (RCTs) that compared acupuncture to sham acupuncture or usual care (UC). The main outcome is complete control (no vomiting episodes and/or no more than mild nausea) of CINV. GRADE approach was used to rate the certainty of evidence.

          Results

          Thirty‐eight RCTs with a total of 2503 patients were evaluated. Acupuncture in addition to UC may increase the complete control of acute vomiting (RR, 1.13; 95% CI, 1.02 to 1.25; 10 studies) and delayed vomiting (RR, 1.47; 95% CI, 1.07 to 2.00; 10 studies) when compared with UC only. No effects were found for all other review outcomes. The certainty of evidence was generally low or very low. None of the predefined moderators changed the overall findings, but in an exploratory moderator analysis we found that an adequate reporting of planned rescue antiemetics might decrease the effect size of complete control of acute vomiting ( p = 0.035).

          Conclusion

          Acupuncture in addition to usual care may increase the complete control of chemotherapy‐induced acute vomiting and delayed vomiting but the certainty of evidence was very low. Well‐designed RCTs with larger sample sizes, standardized treatment regimens, and core outcome measures are needed.

          Abstract

          Acupuncture in addition to usual care may increase the complete control of chemotherapy‐induced acute vomiting and delayed vomiting but the certainty of evidence was very low. A total of 24 different acupoints had been used, most often ST36, PC6, and CV12.

          Related collections

          Most cited references97

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

          The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

            Flaws in the design, conduct, analysis, and reporting of randomised trials can cause the effect of an intervention to be underestimated or overestimated. The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Bias in meta-analysis detected by a simple, graphical test

                Bookmark

                Author and article information

                Contributors
                mail@juergen-barth.de
                Journal
                Cancer Med
                Cancer Med
                10.1002/(ISSN)2045-7634
                CAM4
                Cancer Medicine
                John Wiley and Sons Inc. (Hoboken )
                2045-7634
                24 May 2023
                June 2023
                : 12
                : 11 ( doiID: 10.1002/cam4.v12.11 )
                : 12504-12517
                Affiliations
                [ 1 ] Institute for Complementary and Integrative Medicine University Hospital Zurich and University of Zurich Zurich Switzerland
                [ 2 ] Faculty of Health Sciences Universidad Francisco de Vitoria (UFV) Madrid Spain
                [ 3 ] Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Unidad de bioestadística clínica, Hospital Universitario Ramón y Cajal, (CIBERESP) Madrid Spain
                [ 4 ] Department for Hematology and Oncology Hirslanden Zurich AG Zurich Switzerland
                [ 5 ] Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health, Institute of Social Medicine, Epidemiology and Health Economics Berlin Germany
                [ 6 ] Center for Integrative Medicine University of Maryland School of Medicine Baltimore Maryland USA
                Author notes
                [*] [* ] Correspondence

                Jürgen Barth, Institute for Complementary and Integrative Medicine, University Hospital Zurich, Sonneggstrasse 6, 8091 Zurich, Switzerland.

                Email: mail@ 123456juergen-barth.de

                Author information
                https://orcid.org/0000-0003-1904-5906
                https://orcid.org/0000-0002-1598-8790
                https://orcid.org/0000-0003-4612-460X
                https://orcid.org/0000-0002-5404-2383
                https://orcid.org/0000-0002-5440-7805
                https://orcid.org/0000-0001-7096-7178
                Article
                CAM45962 CAM4-2022-11-5043.R1
                10.1002/cam4.5962
                10278514
                37226372
                76d97809-68e9-4584-b5e8-dccaaa779614
                © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 03 March 2023
                : 14 November 2022
                : 02 April 2023
                Page count
                Figures: 4, Tables: 3, Pages: 14, Words: 8153
                Funding
                Funded by: China Scholarship Council , doi 10.13039/501100004543;
                Award ID: 201906550002
                Categories
                Research Article
                RESEARCH ARTICLES
                Clinical Cancer Research
                Custom metadata
                2.0
                June 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.9 mode:remove_FC converted:19.06.2023

                Oncology & Radiotherapy
                chemotherapy,clinical cancer research,meta‐analysis,side effects
                Oncology & Radiotherapy
                chemotherapy, clinical cancer research, meta‐analysis, side effects

                Comments

                Comment on this article